Sun Yat-sen University: Graves Ophthalmopathy trials

The registry lists 14 Graves Ophthalmopathy studies with Sun Yat-sen University as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 5Phase 3 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Teprotumumab N01 Versus Methylprednisolone After Urgent Orbital Decompression for Dysthyroid Optic NeuropathyNot yet recruitingNCT07594912Phase 2
• Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's OphthalmopathyRecruitingNCT06588764Not applicable
• Multi-model Image of Doxycycline in TAORecruitingNCT05112211Not applicable
• Multi-model Image of Immunosuppressive Agents in TAORecruitingNCT05110040Not applicable
• Efficacy and Safety of Tocilizumab for TAOWithdrawnNCT06087731Phase 2
• Supramaximal Rectus Recession for Strabismus in Grave's OphthalmopathyStatus unknownNCT04927468Not applicable
• Combination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated OphthalmopathyStatus unknownNCT04919694Not applicable
• Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAOStatus unknownNCT04548284Phase 3
• The Therapeutic Effect of Dysthyroid Optic NeuropathyStatus unknownNCT04096612Not applicable
• Natural History and Risk Factors of TAOStatus unknownNCT03515863
• Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal PeopleStatus unknownNCT02290704
• Doxycycline Treatment in Mild Thyroid-Associated OphthalmopathyStatus unknownNCT02203682Phase 2
• Prednisone Versus Doxycycline in the Treatment of Graves' OrbitopathyStatus unknownNCT01809444Phase 2/3
• Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' OrbitopathyCompletedNCT01727973Phase 1/2